Area of research
Endocrinology, Diabetes and Metabolism · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Hormonal Regulation and Hypertension, Heart Failure Treatment and Management, Diabetes Treatment and Management, and Chronic Kidney Disease and Diabetes.
Finerenone in Type 1 Diabetes and Chronic Kidney Disease
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
The Efficacy of Finerenone on Hierarchical Composite Endpoint Analysed Using Win Statistics in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of FINEARTS-HF
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial
Finerenone and Kidney Outcomes in Patients With Heart Failure
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial